Circulating leptin levels predict the development of metabolic syndrome in middle-aged men: an 8-year follow-up study
- PMID: 17620965
- DOI: 10.1097/HJH.0b013e3281afa09e
Circulating leptin levels predict the development of metabolic syndrome in middle-aged men: an 8-year follow-up study
Abstract
Background: Because high circulating plasma leptin is associated with many features of the metabolic syndrome (MS), such as abdominal obesity, insulin resistance and high blood pressure (BP), we analysed the ability of plasma leptin concentration to predict the risk of developing MS in a prospective investigation of adult male participants of the Olivetti Heart Study (OHS).
Methods and results: Three hundred and sixty out of 907 men participating in the 1994-95 and 2002-04 OHS examinations (mean age at baseline 50.4 years, range 25-73 years) were free of MS at first visit according to NCEP-ATP III criteria (modified for the lack of high-density lipoprotein cholesterol measurement at baseline). During an average follow-up period of 8 years, there were 52 incident cases of MS (14.5%) due, in particular, to a rise in the prevalence of high BP (+42.4%), abdominal obesity (+16.4%) and impaired fasting glucose (IFG, +6.1%). In multivariate analyses, a one standard deviation difference in baseline plasma leptin concentration was associated with a 1.58-fold greater risk of developing MS (95% confidence interval = 1.10-2.30, P = 0.016) accounting for age, waist circumference, homeostatic assessment model index, smoking, alcohol consumption and physical activity. In particular, plasma leptin was positively associated with the risk of developing high BP (0.006) and IFG (0.014), after adjustment for confounders.
Conclusion: In this sample of an adult male population free of MS at baseline, circulating plasma leptin was a significant predictor of the risk of MS and, in particular, of its high BP and IFG components, independently of potential confounders.
Similar articles
-
Soluble leptin receptor and leptin are associated with baseline adiposity and metabolic risk factors, and predict adiposity, metabolic syndrome, and glucose levels at 2-year follow-up: the Cyprus Metabolism Prospective Cohort Study.Metabolism. 2011 Jul;60(7):987-93. doi: 10.1016/j.metabol.2010.09.009. Epub 2010 Nov 5. Metabolism. 2011. PMID: 21056886
-
Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome the study from Jiangsu, China of 5 years follow-up.Diabetes Res Clin Pract. 2008 Jul;81(1):117-23. doi: 10.1016/j.diabres.2008.03.008. Epub 2008 May 15. Diabetes Res Clin Pract. 2008. PMID: 18485514
-
Measures of obesity and metabolic syndrome in Indian Americans in northern California.Ethn Dis. 2006 Spring;16(2):331-7. Ethn Dis. 2006. PMID: 17682232
-
Serum uric acid is a determinant of metabolic syndrome in a population-based study.Am J Hypertens. 2006 Oct;19(10):1055-62. doi: 10.1016/j.amjhyper.2006.02.014. Am J Hypertens. 2006. PMID: 17027827
-
[Leptin and metabolic syndrome].Ross Fiziol Zh Im I M Sechenova. 2010 Oct;96(10):945-65. Ross Fiziol Zh Im I M Sechenova. 2010. PMID: 21268827 Review. Russian.
Cited by
-
Circulating leptin levels predict the decline in renal function with age in a sample of adult men (The Olivetti Heart Study).Intern Emerg Med. 2019 Jun;14(4):507-513. doi: 10.1007/s11739-018-1924-9. Epub 2018 Aug 16. Intern Emerg Med. 2019. PMID: 30117101
-
Obstructive sleep apnea, inflammation, and the metabolic syndrome.Metab Syndr Relat Disord. 2009 Aug;7(4):271-8. doi: 10.1089/met.2008.0093. Metab Syndr Relat Disord. 2009. PMID: 19344228 Free PMC article. Review.
-
Abrogation of adenosine A1 receptor signalling improves metabolic regulation in mice by modulating oxidative stress and inflammatory responses.Diabetologia. 2015 Jul;58(7):1610-20. doi: 10.1007/s00125-015-3570-3. Epub 2015 Apr 3. Diabetologia. 2015. PMID: 25835725
-
Neonatal Adipocytokines and Longitudinal Patterns of Childhood Growth.Obesity (Silver Spring). 2019 Aug;27(8):1323-1330. doi: 10.1002/oby.22519. Epub 2019 Jun 14. Obesity (Silver Spring). 2019. PMID: 31199076 Free PMC article.
-
SLC2A9 is a high-capacity urate transporter in humans.PLoS Med. 2008 Oct 7;5(10):e197. doi: 10.1371/journal.pmed.0050197. PLoS Med. 2008. PMID: 18842065 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical